#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Friedreich's ataxia Metastases to peritoneum Neutropenia Methylmalonic acidaemia Kawasaki's disease Sarcoma Extra-osseous Ewing's sarcoma Gestational trophoblastic tumour Atopic keratoconjunctivitis Neurofibroma Ewing's sarcoma recurrent Acute lymphocytic leukaemia Antiphospholipid syndrome Chronic myelomonocytic leukaemia Primary adrenal insufficiency More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome Paraneoplastic neurological syndrome – Basic Information Lymphatic malformation – Trials in Disease Propionic acidaemia – Trials in Disease Medulloblastoma – Life with Disease Niemann-Pick disease – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics Breast angiosarcoma – Basic Information Hairy cell leukaemia – Basic Information Glomerulonephritis rapidly progressive – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omo-103 Aldesleukin RP3 Bi 690517 Nifedipine Ro7589655 Levofloxacin Hemihydrate BROLUCIZUMAB Tisotumab Vedotin Thiamine Nitrate Bp Theophylline Regtivex Niflumic Acid Idecabtagene Vicleucel Dexamfetamine Sulfate [Al[18F]F]Fapi-74 Ecoo16 Rhh646 Anthoxanthum Odoratum Dapirolizumab Pegol More therapies…

    Learn about Your Condition

    Hereditary ataxia Spermatocele Malignant mast cell neoplasm Pulmonary hypertension Hepatic neoplasm Chondrosarcoma Colonoscopy Cardiomyopathy Glanzmann's disease Malignant neoplasm of choroid Sepsis Nicotine dependence Parkinson's disease Osteomyelitis acute Osteomyelitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac sarcoidosis

  • Diagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Finland

  • A Study Testing the Accuracy of 68Ga-Pentixafor PET/CT Imaging in Patients with Cardiac Sarcoidosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    The Netherlands

  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N’,N”-Triacetic Acid, Labelled With Gallium Ga-68
    Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!